201 related articles for article (PubMed ID: 26137206)
21. Treatment for calcium channel blocker poisoning: a systematic review.
St-Onge M; Dubé PA; Gosselin S; Guimont C; Godwin J; Archambault PM; Chauny JM; Frenette AJ; Darveau M; Le Sage N; Poitras J; Provencher J; Juurlink DN; Blais R
Clin Toxicol (Phila); 2014 Nov; 52(9):926-44. PubMed ID: 25283255
[TBL] [Abstract][Full Text] [Related]
22. Risk and benefit of treatment of isolated systolic hypertension in the elderly: evidence from the Systolic Hypertension in Europe Trial.
Celis H; Fagard RH; Staessen JA; Thijs L;
Curr Opin Cardiol; 2001 Nov; 16(6):342-8. PubMed ID: 11704703
[TBL] [Abstract][Full Text] [Related]
23. Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms.
Rouch L; Cestac P; Hanon O; Cool C; Helmer C; Bouhanick B; Chamontin B; Dartigues JF; Vellas B; Andrieu S
CNS Drugs; 2015 Feb; 29(2):113-30. PubMed ID: 25700645
[TBL] [Abstract][Full Text] [Related]
24. Beta-blockers for hypertension.
Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
[TBL] [Abstract][Full Text] [Related]
25. Nicardipine: a hypotensive dihydropyridine-type calcium antagonist with a peculiar cerebrovascular profile.
Amenta F; Tomassoni D; Traini E; Mignini F; Veglio F
Clin Exp Hypertens; 2008 Nov; 30(8):808-26. PubMed ID: 19021030
[TBL] [Abstract][Full Text] [Related]
26. Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers.
Makarounas-Kirchmann K; Glover-Koudounas S; Ferrari P
Clin Ther; 2009 Aug; 31(8):1652-63. PubMed ID: 19808126
[TBL] [Abstract][Full Text] [Related]
27. Calcium channel blockers and stroke.
Inzitari D; Poggesi A
Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):16-30. PubMed ID: 16640170
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of calcium channel blockers in hypertensive patients with concomitant left ventricular dysfunction.
Parmley WW
Clin Cardiol; 1992 Apr; 15(4):235-42. PubMed ID: 1563126
[TBL] [Abstract][Full Text] [Related]
29. Antihypertensive effects of nitrendipine and cilazapril alone, and in combination in hypertensive patients with chronic renal failure.
Kloke HJ; Huysmans FT; Wetzels JF; Sluiter HE; Kleinbloesem CH; Koene RA
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):289S-296S. PubMed ID: 2527541
[TBL] [Abstract][Full Text] [Related]
30. Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.
Lawlor B; Segurado R; Kennelly S; Olde Rikkert MGM; Howard R; Pasquier F; Börjesson-Hanson A; Tsolaki M; Lucca U; Molloy DW; Coen R; Riepe MW; Kálmán J; Kenny RA; Cregg F; O'Dwyer S; Walsh C; Adams J; Banzi R; Breuilh L; Daly L; Hendrix S; Aisen P; Gaynor S; Sheikhi A; Taekema DG; Verhey FR; Nemni R; Nobili F; Franceschi M; Frisoni G; Zanetti O; Konsta A; Anastasios O; Nenopoulou S; Tsolaki-Tagaraki F; Pakaski M; Dereeper O; de la Sayette V; Sénéchal O; Lavenu I; Devendeville A; Calais G; Crawford F; Mullan M;
PLoS Med; 2018 Sep; 15(9):e1002660. PubMed ID: 30248105
[TBL] [Abstract][Full Text] [Related]
31. Nimodipine for primary degenerative, mixed and vascular dementia.
López-Arrieta JM; Birks J
Cochrane Database Syst Rev; 2002; (3):CD000147. PubMed ID: 12137606
[TBL] [Abstract][Full Text] [Related]
32. Questioning the renoprotective role of L-type calcium channel blockers in chronic kidney disease using physiological modeling.
Moore KH; Clemmer JS
Am J Physiol Renal Physiol; 2021 Oct; 321(4):F548-F557. PubMed ID: 34486399
[TBL] [Abstract][Full Text] [Related]
33. Beta-blockers for hypertension.
Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
[TBL] [Abstract][Full Text] [Related]
34. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
Tuomilehto J; Rastenyte D; Birkenhäger WH; Thijs L; Antikainen R; Bulpitt CJ; Fletcher AE; Forette F; Goldhaber A; Palatini P; Sarti C; Fagard R
N Engl J Med; 1999 Mar; 340(9):677-84. PubMed ID: 10053176
[TBL] [Abstract][Full Text] [Related]
35. Cochrane in context: pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
[TBL] [Abstract][Full Text] [Related]
36. Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction.
Matsumoto S; Kondo T; Yang M; Campbell RT; Docherty KF; de Boer RA; Desai AS; Lam CSP; Packer M; Pitt B; Rouleau JL; Vaduganathan M; Zannad F; Zile MR; Solomon SD; Jhund PS; McMurray JJV
Eur J Heart Fail; 2023 Dec; 25(12):2202-2214. PubMed ID: 37771260
[TBL] [Abstract][Full Text] [Related]
37. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.
Forette F; Seux ML; Staessen JA; Thijs L; Birkenhäger WH; Babarskiene MR; Babeanu S; Bossini A; Gil-Extremera B; Girerd X; Laks T; Lilov E; Moisseyev V; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Fagard R
Lancet; 1998 Oct; 352(9137):1347-51. PubMed ID: 9802273
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
[TBL] [Abstract][Full Text] [Related]
40. Dual calcium-channel blocker therapy in the treatment of hypertension.
Saseen JJ; Carter BL
Ann Pharmacother; 1996; 30(7-8):802-10. PubMed ID: 8826565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
